A distinct medicine identity
Trulicity is a prescription brand containing dulaglutide. It belongs in the peptide-medicine discussion, but it should not be described as semaglutide under another name. Ingredient names help readers distinguish related therapeutic discussions without merging different medicines into a single product category. The linked official record is the source for its own indications and warnings.
Why the artwork is specific
The image on this profile is drawn from Trulicity package-label material. It is not a generic pen photo shared across every injectable product. Product-specific artwork makes a reference easier to navigate, while the caption explains its origin. It still cannot prove that an item offered by a third-party seller is genuine.
Avoid informal substitution charts
A chart that puts medicines in neighbouring boxes can suggest a simple equivalence that the evidence does not support. Different substances, presentations and clinical situations require their own information. A web calculator cannot decide a replacement, starting amount or treatment change. Those questions belong with the prescriber and the dispensing pharmacist.
Read a study in full context
When dulaglutide appears in a headline, check which trial is being discussed and which outcomes were actually measured. Separate an approved indication from exploratory analyses or comparisons made across unrelated studies. For a supplied medicine, use the current local leaflet and professional advice instead of interpreting a news summary as use instructions.
Explore the references
Trulicity — identity, evidence and product context ↗Sources & references
A chemical record identifies a reference, a study reports a defined investigation, and a product label concerns a specific medicine. A supplier catalogue is not clinical evidence.
General education, not personal medical advice. Ask an appropriately qualified professional about a medicine, symptom or treatment question.